悦康药业收盘上涨2.73%，滚动市盈率1978.42倍，总市值101.70亿元

金融界2025-07-02

7月2日，悦康药业今日收盘22.6元，上涨2.73%，滚动市盈率PE（当前股价与前四季度每股收益总和的比值）达到1978.42倍，创160天以来新低，总市值101.70亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均54.01倍，行业中值32.98倍，悦康药业排名第144位。股东方面，截至2025年3月31日，悦康药业股东户数14742户，较上次增加360户，户均持股市值35.28万元...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2548899926?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-02 19:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2548899926","market":"sh","top_or_hot":-1,"title":"悦康药业收盘上涨2.73%，滚动市盈率1978.42倍，总市值101.70亿元","media":"金融界","content":"<div>\n<p>7月2日，悦康药业今日收盘22.6元，上涨2.73%，滚动市盈率PE（当前股价与前四季度每股收益总和的比值）达到1978.42倍，创160天以来新低，总市值101.70亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均54.01倍，行业中值32.98倍，悦康药业排名第144位。股东方面，截至2025年3月31日，悦康药业股东户数14742户，较上次增加360户，户均持股市值35.28万元...</p>\n\n<a href=\"https://finance.jrj.com.cn/2025/07/02192351447205.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>悦康药业收盘上涨2.73%，滚动市盈率1978.42倍，总市值101.70亿元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n悦康药业收盘上涨2.73%，滚动市盈率1978.42倍，总市值101.70亿元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-02 19:23 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.jrj.com.cn/2025/07/02192351447205.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>7月2日，悦康药业今日收盘22.6元，上涨2.73%，滚动市盈率PE（当前股价与前四季度每股收益总和的比值）达到1978.42倍，创160天以来新低，总市值101.70亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均54.01倍，行业中值32.98倍，悦康药业排名第144位。股东方面，截至2025年3月31日，悦康药业股东户数14742户，较上次增加360户，户均持股市值35.28万元...</p>\n\n<a href=\"https://finance.jrj.com.cn/2025/07/02192351447205.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688658","symbol_name":"悦康药业","start_time":0,"source_url":"https://finance.jrj.com.cn/2025/07/02192351447205.shtml","article_id":"2548899926","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2548899926","pubTimestamp":1751455407,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"7月2日，悦康药业今日收盘22.6元，上涨2.73%，滚动市盈率PE达到1978.42倍，创160天以来新低，总市值101.70亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均54.01倍，行业中值32.98倍，悦康药业排名第144位。股东方面，截至2025年3月31日，悦康药业股东户数14742户，较上次增加360户，户均持股市值35.28万元，户均持股数量2.76万股。最新一期业绩显示，2025年一季报，公司实现营业收入5.77亿元，同比-40.35%；净利润-49271134.83元，同比-171.09%，销售毛利率44.78%。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688658":"悦康药业","BK0239":"医药制造"},"translate_title":"Yuekang Pharmaceutical closed up 2.73%, with a rolling P/E of 1978.42 times and a total market value of 10.17 billion yuan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688658":1},"content_text":"7月2日，悦康药业今日收盘22.6元，上涨2.73%，滚动市盈率PE（当前股价与前四季度每股收益总和的比值）达到1978.42倍，创160天以来新低，总市值101.70亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均54.01倍，行业中值32.98倍，悦康药业排名第144位。股东方面，截至2025年3月31日，悦康药业股东户数14742户，较上次增加360户，户均持股市值35.28万元，户均持股数量2.76万股。悦康药业集团股份有限公司的主营业务涵盖药品研发,制造,流通销售全产业链条，具备原料,辅料,制剂全产业链的生产能力；产品适应症包括心脑血管,糖尿病,消化系统,抗肿瘤,抗病毒,生殖健康等多个治疗领域，聚焦慢病以及专科治疗领域；产品类型涵盖化药,中药两大类型；产品剂型涵盖注射剂,冻干粉针剂,片剂,胶囊剂等多种剂型。公司实力雄厚，连续多年入选工信部医药工业百强和中国医药研发产品线最佳工业企业。公司“奥美拉唑系列产品产业化与国际化的关键技术开发项目”、“化学药物晶型关键技术体系的建立与应用”先后获得国家科学技术进步二等奖。最新一期业绩显示，2025年一季报，公司实现营业收入5.77亿元，同比-40.35%；净利润-49271134.83元，同比-171.09%，销售毛利率44.78%。序号股票简称PE(TTM)PE(静)市净率总市值(元)13悦康药业1978.4282.202.88101.70亿行业平均54.0152.055.61133.46亿行业中值32.9833.012.5662.42亿1新和成9.5611.202.15657.40亿2浙江医药9.8212.351.30143.38亿3吉林敖东10.5313.070.69202.70亿4华润双鹤11.9211.881.77193.33亿5国药现代12.9413.311.06144.18亿6辰欣药业13.6113.101.0966.65亿7国邦医药13.9014.191.34110.87亿8哈药股份14.2415.061.7094.70亿9健康元14.6914.651.39203.07亿10华特达因14.7115.102.5277.84亿11丽珠集团15.6115.832.30326.20亿12九典制药15.8015.813.1180.98亿","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2548899926","isCrawlerRequest":true}